These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 22624001

  • 1. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
    De Burghgraeve T, Kaptein SJ, Ayala-Nunez NV, Mondotte JA, Pastorino B, Printsevskaya SS, de Lamballerie X, Jacobs M, Preobrazhenskaya M, Gamarnik AV, Smit JM, Neyts J.
    PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
    [Abstract] [Full Text] [Related]

  • 2. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.
    Kaptein SJ, De Burghgraeve T, Froeyen M, Pastorino B, Alen MM, Mondotte JA, Herdewijn P, Jacobs M, de Lamballerie X, Schols D, Gamarnik AV, Sztaricskai F, Neyts J.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5269-80. PubMed ID: 20837762
    [Abstract] [Full Text] [Related]

  • 3. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT, Liu CH, Li JW, Lin CJ, Jassey A, Wu HN, Perng GC, Yen MH, Lin LT.
    Sci Rep; 2020 Oct 02; 10(1):16378. PubMed ID: 33009425
    [Abstract] [Full Text] [Related]

  • 4. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
    De Burghgraeve T, Selisko B, Kaptein S, Chatelain G, Leyssen P, Debing Y, Jacobs M, Van Aerschot A, Canard B, Neyts J.
    Antiviral Res; 2013 May 02; 98(2):242-7. PubMed ID: 23470860
    [Abstract] [Full Text] [Related]

  • 5. Antiviral activity of four types of bioflavonoid against dengue virus type-2.
    Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, Abubakar S.
    Virol J; 2011 Dec 28; 8():560. PubMed ID: 22201648
    [Abstract] [Full Text] [Related]

  • 6. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
    Mastrangelo E, Pezzullo M, De Burghgraeve T, Kaptein S, Pastorino B, Dallmeier K, de Lamballerie X, Neyts J, Hanson AM, Frick DN, Bolognesi M, Milani M.
    J Antimicrob Chemother; 2012 Aug 28; 67(8):1884-94. PubMed ID: 22535622
    [Abstract] [Full Text] [Related]

  • 7. Nucleoside Analogs with Selective Antiviral Activity against Dengue Fever and Japanese Encephalitis Viruses.
    Zandi K, Bassit L, Amblard F, Cox BD, Hassandarvish P, Moghaddam E, Yueh A, Libanio Rodrigues GO, Passos I, Costa VV, AbuBakar S, Zhou L, Kohler J, Teixeira MM, Schinazi RF.
    Antimicrob Agents Chemother; 2019 Jul 28; 63(7):. PubMed ID: 31061163
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of hepatitis C virus replication by semi-synthetic derivatives of glycopeptide antibiotics.
    Obeid S, Printsevskaya SS, Olsufyeva EN, Dallmeier K, Durantel D, Zoulim F, Preobrazhenskaya MN, Neyts J, Paeshuyse J.
    J Antimicrob Chemother; 2011 Jun 28; 66(6):1287-94. PubMed ID: 21436155
    [Abstract] [Full Text] [Related]

  • 9. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC, Hu HS, Lin HM, Wu PS, Wu RH, Tian JN, Wu SH, Tsou LK, Song JS, Chen HW, Chern JH, Chen CT, Yueh A.
    Antiviral Res; 2019 Dec 28; 172():104636. PubMed ID: 31654671
    [Abstract] [Full Text] [Related]

  • 10. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V.
    Antiviral Res; 2020 Apr 28; 176():104749. PubMed ID: 32081740
    [Abstract] [Full Text] [Related]

  • 11. Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses.
    Eyer L, Zouharová D, Širmarová J, Fojtíková M, Štefánik M, Haviernik J, Nencka R, de Clercq E, Růžek D.
    Antiviral Res; 2017 Jun 28; 142():63-67. PubMed ID: 28336346
    [Abstract] [Full Text] [Related]

  • 12. Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication.
    van Cleef KW, Overheul GJ, Thomassen MC, Kaptein SJ, Davidson AD, Jacobs M, Neyts J, van Kuppeveld FJ, van Rij RP.
    Antiviral Res; 2013 Aug 28; 99(2):165-71. PubMed ID: 23735301
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi PY.
    J Virol; 2011 Jul 28; 85(13):6548-56. PubMed ID: 21507975
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
    Lee JC, Tseng CK, Wu YH, Kaushik-Basu N, Lin CK, Chen WC, Wu HN.
    Antiviral Res; 2015 Apr 28; 116():1-9. PubMed ID: 25614455
    [Abstract] [Full Text] [Related]

  • 15. Antiviral activity of silymarin and baicalein against dengue virus.
    Low ZX, OuYong BM, Hassandarvish P, Poh CL, Ramanathan B.
    Sci Rep; 2021 Oct 27; 11(1):21221. PubMed ID: 34707245
    [Abstract] [Full Text] [Related]

  • 16. Betulinic acid exhibits antiviral effects against dengue virus infection.
    Loe MWC, Hao E, Chen M, Li C, Lee RCH, Zhu IXY, Teo ZY, Chin WX, Hou X, Deng J, Chu JJH.
    Antiviral Res; 2020 Dec 27; 184():104954. PubMed ID: 33080251
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of dengue virus by an ester prodrug of an adenosine analog.
    Chen YL, Yin Z, Lakshminarayana SB, Qing M, Schul W, Duraiswamy J, Kondreddi RR, Goh A, Xu HY, Yip A, Liu B, Weaver M, Dartois V, Keller TH, Shi PY.
    Antimicrob Agents Chemother; 2010 Aug 27; 54(8):3255-61. PubMed ID: 20516277
    [Abstract] [Full Text] [Related]

  • 18. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
    Beesetti H, Tyagi P, Medapi B, Krishna VS, Sriram D, Khanna N, Swaminathan S.
    Antivir Ther; 2018 Aug 27; 23(5):385-394. PubMed ID: 29583121
    [Abstract] [Full Text] [Related]

  • 19. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA, Palanisamy UD, Tejo BA, Chew MF, Tham HW, Syed Hassan S.
    Virol J; 2017 Nov 21; 14(1):229. PubMed ID: 29162124
    [Abstract] [Full Text] [Related]

  • 20. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells.
    Panya A, Songprakhon P, Panwong S, Jantakee K, Kaewkod T, Tragoolpua Y, Sawasdee N, Lee VS, Nimmanpipug P, Yenchitsomanus PT.
    Molecules; 2021 May 23; 26(11):. PubMed ID: 34071102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.